Bio-Techne Corporation (TECH)
After hours:
| Previous Close | 76.06 |
| Open | 76.87 |
| Bid | 77.44 x 300 |
| Ask | 77.52 x 300 |
| Day's Range | 76.03 - 77.58 |
| 52 Week Range | 51.79 - 89.91 |
| Volume | |
| Avg. Volume | 1,115,668 |
| Market Cap | 12.207B |
| Beta (5Y Monthly) | 1.22 |
| PE Ratio (TTM) | 61.97 |
| EPS (TTM) | 1.25 |
| Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | 0.32 (0.41%) |
| Ex-Dividend Date | May 10, 2024 |
| 1y Target Est | 83.36 |
PR NewswireBIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its portfolio of cell and gene therapy workflow solutions at the upcoming annual meeting of the American Society of Gene & Cell Therapy (ASGCT), taking place May 7-11, 2024, in Baltimore, Maryland.
Simply Wall St.Bio-Techne Corporation Just Recorded A 7.6% EPS Beat: Here's What Analysts Are Forecasting Next
Bio-Techne Corporation ( NASDAQ:TECH ) defied analyst predictions to release its quarterly results, which were ahead of...
Insider MonkeyBio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript
Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript May 1, 2024 Bio-Techne Corporation beats earnings expectations. Reported EPS is $0.48, expectations were $0.46. Bio-Techne Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the Bio-Techne […]
